{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:57:10Z","timestamp":1790351830277,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T00:00:00Z","timestamp":1506124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grifols Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Non-cystic fibrosis bronchiectasis (NCFBE) is a rare, chronic lung disease characterized by bronchial inflammation and permanent airway dilation. Chronic infections with P. aeruginosa have been linked to higher morbidity and mortality. To understand the impact of P. aeruginosa in NCFBE on health care costs and burden, we assessed healthcare costs and utilization before and after P. aeruginosa diagnosis. Using data from 2007 to 2013 PharMetrics Plus administrative claims, we included patients with \u22652 claims for bronchiectasis and &gt;1 claim for P. aeruginosa; then excluded those with a claim for cystic fibrosis. Patients were indexed at first claim for P. aeruginosa and were required to have &gt;12 months before and after the index P. aeruginosa. The mean differences in utilization and costs were assessed using paired Student\u2019s t-tests for statistical significance. Mean total healthcare costs per patient were $36,213 pre-P. aeruginosa diagnosis versus $67,764 post-P. aeruginosa, an increase of 87% (p &lt; 0.0001). Inpatient costs represented the largest proportion of total healthcare costs post-P. aeruginosa (54%) with an increase of four hospitalizations per patient (p &lt; 0.0001). NCFBE patients with evidence of P. aeruginosa incur substantially greater healthcare costs and utilization after P. aeruginosa diagnosis. Future research should explore methods of earlier identification of NCFBE patients with P. aeruginosa, as this may lead to fewer severe exacerbations, thereby resulting in a reduction in hospitalizations and healthcare costs.<\/jats:p>","DOI":"10.3390\/medsci5040020","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T04:28:01Z","timestamp":1506400081000},"page":"20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S."],"prefix":"10.3390","volume":"5","author":[{"given":"Christopher","family":"Blanchette","sequence":"first","affiliation":[{"name":"University of North Carolina at Charlotte, Department of Public Health Sciences, Charlotte, NC 28223, USA"},{"name":"Precision Health Economics, Huntersville, NC 28078, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Noone","sequence":"additional","affiliation":[{"name":"University of North Carolina at Charlotte, Department of Public Health Sciences, Charlotte, NC 28223, USA"},{"name":"Precision Health Economics, Huntersville, NC 28078, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Stone","sequence":"additional","affiliation":[{"name":"Grifols, Durham, NC 27709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Zacherle","sequence":"additional","affiliation":[{"name":"University of North Carolina at Charlotte, Department of Public Health Sciences, Charlotte, NC 28223, USA"},{"name":"Precision Health Economics, Huntersville, NC 28078, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ripsi","family":"Patel","sequence":"additional","affiliation":[{"name":"University of North Carolina at Charlotte, Department of Public Health Sciences, Charlotte, NC 28223, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Howden","sequence":"additional","affiliation":[{"name":"University of North Carolina at Charlotte, Department of Public Health Sciences, Charlotte, NC 28223, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Mapel","sequence":"additional","affiliation":[{"name":"University of New Mexico College of Pharmacy, Albuquerque, NM 87131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Weycker, D., Hansen, G.L., and Seifer, F.D. (2017). Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chronic Respir. Dis.","DOI":"10.1177\/1479972317709649"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of pseudomonas persistence and resistance","volume":"109","author":"McDonnell","year":"2015","journal-title":"Respir. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clin. Pulm. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40258-013-0027-z","article-title":"Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective","volume":"11","author":"Joish","year":"2013","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Evans, D.J., Bara, A.I., and Greenstone, M. (2003). Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD001392"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.08-0776","article-title":"Bronchiectasis","volume":"134","year":"2008","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Felix, L.M., Grundy, S., Milan, S.J., Armstrong, R., Harrison, H., Lynes, D., and Spencer, S. (2017). Dual antibiotics for non-cystic fibrosis bronchiectasis (protocol). Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD012514"},{"key":"ref_8","first-page":"6","article-title":"Inflammation: A two-edged sword\u2014the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur. J. Respir. Dis. Suppl."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rmed.2016.06.007","article-title":"Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"117","author":"Wilson","year":"2016","journal-title":"Respir. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1183\/09031936.97.10081754","article-title":"Effect of sputum bacteriology on the quality of life of patients with bronchiectasis","volume":"10","author":"Wilson","year":"1997","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-13-21","article-title":"Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: A retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients","volume":"13","author":"Goeminne","year":"2012","journal-title":"Respir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1183\/09031936.06.00074605","article-title":"The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis","volume":"28","author":"Davies","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.11-1024","article-title":"Bronchiectasis in a diverse US population: Effects of ethnicity on etiology and sputum culture","volume":"142","author":"McShane","year":"2012","journal-title":"Chest"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respir. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1183\/09031936.96.09081601","article-title":"Lung function in bronchiectasis: The influence of Pseudomonas aeruginosa","volume":"9","author":"Evans","year":"1996","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Soriano","year":"2007","journal-title":"Chest"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Guan, W.J., Gao, Y.H., Xu, G., Lin, Z.Y., Tang, Y., Li, H.M., Lin, Z.M., Zheng, J.P., Chen, R.C., and Zhong, N.S. (2014). Characterization of lung function impairment in adults with bronchiectasis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113373"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2012-203105","article-title":"Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition","volume":"68","author":"Rogers","year":"2013","journal-title":"Thorax"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","article-title":"A novel microbiota stratification system predicts future exacerbations in bronchiectasis","volume":"11","author":"Rogers","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: A long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/thoraxjnl-2013-203739","article-title":"National BTS bronchiectasis audit 2012: Is the quality standard being adhered to in adult secondary care?","volume":"69","author":"Hill","year":"2014","journal-title":"Thorax"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","article-title":"Microbiologic follow-up study in adult bronchiectasis","volume":"101","author":"King","year":"2007","journal-title":"Respir. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yayan, J., Ghebremedhin, B., and Rasche, K. (2015). Antibiotic resistance of Pseudomonas aeruginosa in pneumonia at a single university hospital center in Germany over a 10-year period. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139836"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","article-title":"Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation","volume":"187","author":"Tunney","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_28","first-page":"CD004197","article-title":"Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis","volume":"4","author":"Smyth","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_29","unstructured":"(2017, September 20). Quintiles IMS. Available online: http:\/\/www.imshealth.com\/en."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.prrv.2010.05.003","article-title":"Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis","volume":"11","author":"Stuart","year":"2010","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British thoracic society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1157\/13128330","article-title":"Diagnosis and treatment of bronchiectasis. Spanish society of pneumology and thoracic surgery","volume":"44","author":"Vendrell","year":"2008","journal-title":"Archivos de Bronconeumolog\u00eda"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S1569-1993(11)60011-8","article-title":"Chronic Pseudomonas aeruginosa infection definition: EuroCareCF working group report","volume":"10","author":"Pressler","year":"2011","journal-title":"J Cyst. Fibros."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/5\/4\/20\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:45:46Z","timestamp":1760208346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/5\/4\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["medsci5040020"],"URL":"https:\/\/doi.org\/10.3390\/medsci5040020","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,23]]}}}